NORTHERN TRUST CORP - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 45 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$25,993
-7.2%
74,2670.0%0.00%
Q3 2022$28,000
-17.6%
74,2670.0%0.00%
Q2 2022$34,000
-8.1%
74,2670.0%0.00%
Q1 2022$37,000
-11.9%
74,2670.0%0.00%
Q4 2021$42,000
-44.7%
74,2670.0%0.00%
Q3 2021$76,000
-14.6%
74,2670.0%0.00%
Q2 2021$89,000
-8.2%
74,267
-0.1%
0.00%
Q1 2021$97,000
-51.3%
74,348
+36.9%
0.00%
Q4 2020$199,000
+63.1%
54,320
-4.9%
0.00%
Q3 2020$122,000
+25.8%
57,143
+5.4%
0.00%
Q2 2020$97,000
+34.7%
54,229
-0.3%
0.00%
Q1 2020$72,000
-21.7%
54,365
+7.3%
0.00%
Q4 2019$92,000
-48.6%
50,668
-18.0%
0.00%
Q3 2019$179,000
-71.2%
61,783
-73.4%
0.00%
Q2 2019$622,000
+1.0%
232,673
-3.6%
0.00%
Q1 2019$616,000
-8.6%
241,444
-0.7%
0.00%
Q4 2018$674,000
-68.9%
243,197
-0.2%
0.00%
-100.0%
Q3 2018$2,170,000243,6120.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 56,250$206,0000.12%
Baker Brothers Advisors 4,608,786$16,914,0000.06%
Artal Group S.A. 500,000$1,835,0000.04%
HOLLENCREST CAPITAL MANAGEMENT 90,000$331,0000.04%
Spotlight Asset Group, Inc. 21,500$79,0000.03%
DCF Advisers, LLC 18,755$69,0000.03%
683 Capital Management, LLC 88,470$325,0000.02%
Palo Alto Investors LP 77,044$283,0000.02%
Alpine Global Management, LLC 13,966$51,0000.01%
TCI Wealth Advisors, Inc. 4,000$15,0000.01%
View complete list of IDERA PHARMACEUTICALS INC shareholders